Health and Healthcare

Friday's Top Biotech & Medical Stocks

by H.S. Ayoub
BioHealth Investor.com

Biotechnology

IDM PHARMA INC [IDMI] +35.23%
LPATH INC [LPTN.OB] +11.11%
EXACT SCIENCES COR [EXAS] +8.30%
GENVEC INC [GNVC] +7.53%
HEMOBIOTECH INC [HMBT.OB] +5.95%

Diagnostic Substances

ICAGEN, INC. [ICGN] +19.53%
NYMOX PHARM CORP [NYMX] +14.31%
ROSETTA GENOMICS LTD [ROSG] +7.81%
QUIDEL CP [QDEL] +6.42%
PONIARD PHARMA [PARD] +4.67%

Drug Delivery

INSITE VISION INC [ISV] +12.75%
QUIGLEY CORP THE [QGLY] +3.87%
BIOVAIL CORP [BVF] +2.19%
PENWEST PHARM CO [PPCO] +1.92%
NOVADEL PHARMA INC [NVD] +0.79%

Drug Manufacturers

ARQULE INC [ARQL] +8.00%
INSPIRE PHARMACEUT [ISPH] +7.74%
DUSA PHARM INC [DUSA] +7.19%
ATHEROGENICS INC [AGIX] +6.21%
NEXMED INC [NEXM] +4.62%

Drug Related Products

XELR8 HOLDINGS, INC [BZI] +11.40%
IMAGENETIX INC [IAGX.OB] +4.17%
LABOPHARM INC. [DDSS] +3.71%
NATROL INC [NTOL] +1.31%
ZILA INC [ZILA] +1.01%

Generic Drugs

CARACO PHARMA LABS [CPD] +2.37%
HI-TECH PHARMACAL [HITK] +0.52%
PHARMACUTICAL CO [PRX] +0.45%

Medical Appliances & Equipment

ALPHA INNOTECH [APNO.OB] +10.37%
ARTHROCARE CP [ARTC] +7.53%
MICROTEK MED HLDGS [MTMD] +6.77%
QMED INC [QMED] +6.62%
AMER MED ALERT CP [AMAC] +3.28%

Medical Instruments & Supplies

ENPATH MED INC [NPTH] +9.66%
MEMRY CORPORATION [MRY] +8.42%
DIOMED HOLDINGS INC [DIO] +8.09%
AMDL, INC [ADL] +7.97%
ENDOLOGIX INC [ELGX] +6.02%

Medical Laboratories & Research

NEOGENOMICS INC [NGNM.OB] +8.11%
ERESEARCHTECHNOLOG [ERES] +5.97%
MEDTOX SCIENTFIC INC [MTOX] +3.97%
BIO-IMAGING TECH [BITI] +3.25%
OSI PHARMACEUTIC [OSIP] +0.50%

The Easy Way To Retire Early

You can retire early from the lottery, luck, or loving family member who leaves you a fortune.

But for the rest of us, there are dividends. While everyone chases big name dividend kings, they’re missing the real royalty: dividend legends.

It’s a rare class of overlooked income machines that you could buy and hold – forever.

Click here now to see two that could help you retire early, without any luck required.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.